- Home
- ALX vs INVA Comparison
ALX vs INVA Comparison
Compare ALX & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALX
- INVA
- Stock Information
- Founded
- ALX 1928
- INVA 1996
- Country
- ALX United States
- INVA United States
- Employees
- ALX N/A
- INVA N/A
- Industry
- ALX Real Estate Investment Trusts
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- ALX Real Estate
- INVA Health Care
- Exchange
- ALX Nasdaq
- INVA Nasdaq
- Market Cap
- ALX 1.2B
- INVA 1.1B
- IPO Year
- ALX N/A
- INVA 2004
- Fundamental
- Price
- ALX $207.55
- INVA $21.21
- Analyst Decision
- ALX
- INVA Buy
- Analyst Count
- ALX 0
- INVA 5
- Target Price
- ALX N/A
- INVA $36.60
- AVG Volume (30 Days)
- ALX 60.7K
- INVA 890.6K
- Earning Date
- ALX 11-03-2025
- INVA 11-05-2025
- Dividend Yield
- ALX 8.67%
- INVA N/A
- EPS Growth
- ALX N/A
- INVA 53.96
- EPS
- ALX 7.14
- INVA 1.52
- Revenue
- ALX $215,838,000.00
- INVA $388,521,000.00
- Revenue This Year
- ALX N/A
- INVA $7.98
- Revenue Next Year
- ALX N/A
- INVA $11.60
- P/E Ratio
- ALX $29.07
- INVA $13.75
- Revenue Growth
- ALX N/A
- INVA 10.14
- 52 Week Low
- ALX $184.76
- INVA $16.52
- 52 Week High
- ALX $260.84
- INVA $22.76
- Technical
- Relative Strength Index (RSI)
- ALX 39.00
- INVA 63.38
- Support Level
- ALX $201.28
- INVA $20.68
- Resistance Level
- ALX $225.06
- INVA $22.48
- Average True Range (ATR)
- ALX 6.52
- INVA 0.81
- MACD
- ALX -1.32
- INVA -0.01
- Stochastic Oscillator
- ALX 25.36
- INVA 69.33
About ALX Alexander's Inc.
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.